Tumor cell-derived human angiopoietin-like protein 4 (ANGPTL4) has been shown to disrupt vascular endothelial cell connections, enhance pulmonary capillary permeability, and facilitate tumor cell protrusion through the vascular endothelium, which is involved in lung cancer [76]. Here, ANGPTL4 is linked to lung carcinoma.